Sept 2022: Ibrutinib (Imbruvica, Pharmacyclics LLC) yakabvumidzwa neFood and Drug Administration kuti ishandiswe muvarwere vevana vane chirwere chisingaperi chinopesana nechirwere chechirwere (cGVHD) vari vadiki pane 1 gore uye vakundikana.
Kurume 2022: Abatacept (Orencia, Bristol-Myers Squibb Kambani) yakatenderwa neFood and Drug Administration kudzivirira acute graft versus host hosha (aGVHD) muvakuru uye varwere vevana vane makore maviri ezera.
Gumiguru 2021: Mushure mekutadza kwemutsara mumwe kana maviri wesystemic therapy, iyo Food and Drug Administration yakabvumidza ruxolitinib (Jakafi, Incyte Corp.) yechirwere chegraft-versus-host disease (cGVHD) muvakuru nevana vane makore gumi nemaviri zvichikwira...
Nyamavhuvhu 2021: Mushure mekundikana kweanopfuura maviri mitsara yepamberi yekurapa systemic, Chikafu neDrug Administration yakabvumidza belumosudil (Rezurock, Kadmon Pharmaceuticals, LLC), kinase inhibitor, yevakuru uye yevarwere vane gumi nevaviri imi ..
Chikunguru 2021: Beta-thalassemia inzvimbo yakagarwa nhaka inokonzerwa nekushanduka kwejeni rine chekuita nekugadzirwa kwechikamu chehemoglobin, puroteni inotakura okisijeni mumuviri wese. Idzi shanduko dzinorambidza ..
Bone marrow transplants muIndia Bone marrow stem cell transplants muIndia inoitwa nedzimwe nzvimbo dzinotungamira kenza. Kusvika iye zvino, kupfuura 10,000 yakabudirira bone marrow stem cell transplants yakaitwa muIndia. ..
Iyi nyaya ndeyekuisirwa mwongo muIndia. Mukhtar, anobva kuAssela kuEthiopia, ane chirwere chinouraya chinonzi aplastic anemia. Anoenda kuIndia kuti aisirwe stem cell. Verenga nyaya yese pano. Mukhtar Mukhtar ndiye..